ANI Pharmaceuticals Inc (NASDAQ:ANIP) shares are down 1.5% today after the company released fourth-quarter net earnings of $20.
In a research report published Monday, Roth Capital analyst Scott Henry reiterated a Buy rating on Catalyst Pharmaceutical (NASDAQ:CPRX) with a $6.00 price …
Roth Capital analyst Scott Henry reiterated a Buy rating on Biodelivery Sciences (NASDAQ:BDSI) with a price target of $18.00, as the company announced that it …
In a research report released today, Roth Capital analyst Scott Henry initiated coverage on shares of Titan Pharmaceuticals (OTC:TTNP) with a $1.25 price target, which represents …
In a research report published Friday, Roth Capital analyst Scott Henry upgraded shares of Depomed (NASDAQ:DEPO) from a Neutral to a Buy rating and …
In a research report sent to investors today, Roth Capital analyst Scott Henry reiterated a Buy rating on Tonix Pharmaceuticals (NASDAQ:TNXP) with a …
In a research report released today, Roth Capital analyst Scott Henry reiterated a Buy rating on RedHill Biopharma (NASDAQ:RDHL) with a $27.50 price …
In a research report issued today, Roth Capital analyst Scott Henry reiterated a Buy rating on Neuroderm (NASDAQ:NDRM) with a $17.50 price target, …
In a research report published Friday, Roth Capital analyst Scott Henry upgraded shares of Biodelivery Sciences (NASDAQ:BDSI) from Hold to Buy rating, but reduced his …
In a research report issued today, Roth Capital analyst Scott Henry reiterated a Buy rating on RedHill Biopharma (NASDAQ:RDHL) and raised his price …
